David Dantzker

David Dantzker

Director/Board Member at SURMODICS, INC.

Net worth: 2 M $ as of 2024-05-30

80 year
Health Technology
Commercial Services
Consumer Services

Profile

David R.
Dantzker
is the founder of Oligomerix, Inc. (founded in 2006) and holds the title of Director.
He is also the founder of The Feinstein Institutes for Medical Research.
Dr. Dantzker's current job positions include Deputy Chairman & Chief Medical Officer at Origin Life Sciences, Inc. (since 2012), Independent Director at Surmodics, Inc. (since 2011), Director at ShiftWise, Inc., Director at Shire Regenerative Medicine, Inc., and Partner at Wheatley Partners LP.
He is also a Partner at Wheatley Medtech Partners LP (since 2001) and Wheatley Partners (since 2001).
Dr. Dantzker's former job positions include Chief Executive Officer at Redox Pharmaceutical Corp.
(2000-2001), President & Chief Executive Officer at Long Island Jewish Medical Center (1993-1997), Chairman at American Board of Internal Medicine, Chairman at Versamed Medical Systems LLC, Director at CNS, Inc. (Delaware), Director at Datascope Corp.
(2008-2009), Director at Agilix Corp., Director at Valera Pharmaceuticals, Inc. (2003-2007), Director at Comprehensive NeuroScience, Inc., Treasurer & Director at Physicians for Human Rights, Director at Woodbrook Group Holdings, Inc., Independent Non-Executive Director at Respiri Ltd.
(2012-2014), Director at NovaRay Medical, Inc., Director at VisionSense Ltd., Director at Care Management Technologies, Inc., Director at Comprehensive Clinical Development, Inc., Professor-Medicine at the University of Michigan, President at Northwell Health, Inc. (1997-2000), Professor-Medicine at Albert Einstein College of Medicine, Inc., and Professor-Medicine at The University of Texas at Austin.
Dr. Dantzker's education includes an undergraduate degree from New York University and a doctorate degree from Jacobs School of Medicine & Biomedical Sciences.
Dr. Dantzker is also the founder of The Feinstein Institutes for Medical Research.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-07 39,124 ( 0.27% ) 2 M $ 2024-05-30

David Dantzker active positions

CompaniesPositionStart
SURMODICS, INC. Director/Board Member 2011-01-04
Director/Board Member -
Corporate Officer/Principal 2000-12-31
Wheatley Partners LP Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer 2011-12-31
Founder 2005-12-31
Private Equity Investor 2000-12-31
Director/Board Member -
All active positions of David Dantzker

Former positions of David Dantzker

CompaniesPositionEnd
RESPIRI LIMITED Director/Board Member 2014-02-04
░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of David Dantzker's experience

Training of David Dantzker

New York University Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Dantzker's experience

Connections

97

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
WOODBROOK GROUP HOLDINGS INC.

Finance

SURMODICS, INC.

Health Technology

RESPIRI LIMITED

Health Technology

Private companies23

Health Technology

Health Technology

Finance

Distribution Services

Electronic Technology

Process Industries

Retail Trade

Commercial Services

Health Technology

Retail Trade

Commercial Services

Health Services

Commercial Services

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Wheatley Partners LP

Finance

Finance

Health Services

Commercial Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. David Dantzker